These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34981764)

  • 1. Identification and characterization of two drug-like fragments that bind to the same cryptic binding pocket of Burkholderia pseudomallei DsbA.
    Petit GA; Mohanty B; McMahon RM; Nebl S; Hilko DH; Wilde KL; Scanlon MJ; Martin JL; Halili MA
    Acta Crystallogr D Struct Biol; 2022 Jan; 78(Pt 1):75-90. PubMed ID: 34981764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide-dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei.
    Nebl S; Alwan WS; Williams ML; Sharma G; Taylor A; Doak BC; Wilde KL; McMahon RM; Halili MA; Martin JL; Capuano B; Fenwick RB; Mohanty B; Scanlon MJ
    J Biomol NMR; 2020 Nov; 74(10-11):595-611. PubMed ID: 32761504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disarming Burkholderia pseudomallei: structural and functional characterization of a disulfide oxidoreductase (DsbA) required for virulence in vivo.
    Ireland PM; McMahon RM; Marshall LE; Halili M; Furlong E; Tay S; Martin JL; Sarkar-Tyson M
    Antioxid Redox Signal; 2014 Feb; 20(4):606-17. PubMed ID: 23901809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets.
    Vezina B; Petit GA; Martin JL; Halili MA
    PLoS One; 2020; 15(11):e0241306. PubMed ID: 33216758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
    McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials.
    Wang G; Mohanty B; Williams ML; Doak BC; Dhouib R; Totsika M; McMahon RM; Sharma G; Zheng D; Bentley MR; Ka-Yan Chin Y; Horne J; Chalmers DK; Heras B; Scanlon MJ
    ChemMedChem; 2022 Mar; 17(6):e202100673. PubMed ID: 34978144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure analysis of the extracellular domain reveals disulfide bond forming-protein properties of Mycobacterium tuberculosis Rv2969c.
    Wang L; Li J; Wang X; Liu W; Zhang XC; Li X; Rao Z
    Protein Cell; 2013 Aug; 4(8):628-40. PubMed ID: 23828196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Thioredoxin Partner of Vitamin K Epoxide Reductase in Mycobacterial Disulfide Bond Formation.
    Ke N; Landeta C; Wang X; Boyd D; Eser M; Beckwith J
    J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of reduced and oxidized DsbA: investigation of domain motion and thiolate stabilization.
    Guddat LW; Bardwell JC; Martin JL
    Structure; 1998 Jun; 6(6):757-67. PubMed ID: 9655827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.
    Neckles C; Eltschkner S; Cummings JE; Hirschbeck M; Daryaee F; Bommineni GR; Zhang Z; Spagnuolo L; Yu W; Davoodi S; Slayden RA; Kisker C; Tonge PJ
    Biochemistry; 2017 Apr; 56(13):1865-1878. PubMed ID: 28225601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei.
    Begley DW; Hartley RC; Davies DR; Edwards TE; Leonard JT; Abendroth J; Burris CA; Bhandari J; Myler PJ; Staker BL; Stewart LJ
    J Struct Funct Genomics; 2011 Jul; 12(2):63-76. PubMed ID: 21359640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics.
    Del Prete S; Vullo D; Di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem; 2017 Jan; 25(2):575-580. PubMed ID: 27914949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA.
    Adams LA; Sharma P; Mohanty B; Ilyichova OV; Mulcair MD; Williams ML; Gleeson EC; Totsika M; Doak BC; Caria S; Rimmer K; Horne J; Shouldice SR; Vazirani M; Headey SJ; Plumb BR; Martin JL; Heras B; Simpson JS; Scanlon MJ
    Angew Chem Int Ed Engl; 2015 Feb; 54(7):2179-84. PubMed ID: 25556635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fragment-Based Development of a Benzofuran Hit as a New Class of
    Duncan LF; Wang G; Ilyichova OV; Scanlon MJ; Heras B; Abbott BM
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31635355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate.
    Blain JM; Grote DL; Watkins SM; Goshu GM; Muller C; Gorman JL; Ranieri G; Walter RL; Hofstetter H; Horn JR; Hagen TJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128273. PubMed ID: 34298132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-atomic resolution analysis of BipD, a component of the type III secretion system of Burkholderia pseudomallei.
    Pal M; Erskine PT; Gill RS; Wood SP; Cooper JB
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Sep; 66(Pt 9):990-3. PubMed ID: 20823511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of TcpG, the DsbA protein folding catalyst from Vibrio cholerae.
    Hu SH; Peek JA; Rattigan E; Taylor RK; Martin JL
    J Mol Biol; 1997 Apr; 268(1):137-46. PubMed ID: 9149147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis.
    Del Prete S; Vullo D; Di Fonzo P; Osman SM; AlOthman Z; Donald WA; Supuran CT; Capasso C
    Bioorg Med Chem Lett; 2017 Feb; 27(3):490-495. PubMed ID: 28025002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
    Loaiza CD; Duhan N; Lister M; Kaundal R
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.